Target
Integrin-linked protein kinase
Ligand
BDBM123923
Substrate
n/a
Meas. Tech.
In Vitro Ezyme Assay
Temperature
313.15±n/a K
IC50
200±n/a nM
Comments
extracted
Citation
 Zhang, ZDaynard, TSWang, SDu, XChopiuk, GBYan, JChen, JSviridov, SV Pyrazolylbenzothiazole derivatives and their use as therapeutic agents US Patent  US8754233 Publication Date 6/17/2014
Target
Name:
Integrin-linked protein kinase
Synonyms:
ILK | ILK1 | ILK2 | ILK_HUMAN | Integrin-linked protein kinase (ILK) | Serine/threonine-protein kinase ILK-1
Type:
Protein
Mol. Mass.:
51429.75
Organism:
Homo sapiens (Human)
Description:
Q13418
Residue:
452
Sequence:
MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIPYKDTFWKGTTRTRPRNGTLNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQCPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVCKLMKICMNEDPAKRPKFDMIVPILEKMQDK
  
Inhibitor
Name:
BDBM123923
Synonyms:
US8754233, (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine
Type:
Small organic molecule
Emp. Form.:
C15H14N6S
Mol. Mass.:
310.377
SMILES:
C(Cc1cnc[nH]1)Nc1[nH]ncc1-c1nc2ccccc2s1
Structure:
Search PDB for entries with ligand similarity: